NCT05033522 - Immunotherapy for Advanced Liver Cancer | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

November 1, 2026

Study Completion Date

December 1, 2026

Conditions

Hepatocellular Carcinoma

Interventions

BIOLOGICAL

AlloStim® immunotherapy

3 cycles of intradermal and intravenous administrations

DRUG

FOLFOX regimen

Comparative arm: Physician Choice of FOLFOX4 chemotherapy

DRUG

Sorafenib

Comparative arm: Physician Choice of Sorafenib

DRUG

Lenvatinib

Comparative Arm: Physician's Choice of Levantinib

Trial Locations (8)

Siriraj Hospital, Bangkok Noi

Columbia Asia Bukit Rimau, Shah Alam

Naresuan University Hospital, Phitsanulok

Sultan Ismail Hospital, Johor Bahru

Prince of Songkla University (Songklanagarind Hospital), Hat Yai

Sultanah Bahiyah Hospital, Alor Star

Chiangmai University, Chiang Mai

Songklanagarind Hospital, Khon Kaen